CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 50 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00395044
NCT00395044Phase 2Completed
CompareCT.gov

Gabapentin for Cannabis Withdrawal and Use

The Scripps Research Institute·interventional·Posted Nov 2, 2006·Updated Feb 10, 2017

In Brief

A Phase 2 clinical trial evaluating Placebo and Gabapentin for Cannabis Dependence. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This is a study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCannabis Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 2, 2006
Enrollment StartAug 1, 2006
Primary CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 19.7 years ago

Interventions

Placebodrug

Placebo

Gabapentindrug